Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET
Company Participants
Patti Bank - Investor Relations
John Jacobs - President and Chief Executive Officer
Jeffrey Dierks - Chief Commercial Officer
Jeffrey Dayno - Chief Medical Officer
Sandip Kapadia - Chief Financial Officer
Conference Call Participants
Chris Howerton - Jefferies
Ami Fadia - Needham and Company
David Amsellem - Piper Sandler
Danielle Brill - Raymond James
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Harmony Biosciences Third Quarter 2021 Financial Update Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]
I would now like to turn the conference over to your speaker for today, Patti Bank. You may begin.
Patti Bank
Thank you, operator. Good morning everyone and thank you for joining us today as we review Harmony Biosciences third quarter 2021 financial performance and provide a business update.
Before we start, I encourage everyone to go to the Investors Section of the Harmony Biosciences website to find the press release and slides that accompany our discussion today, including a reconciliation of our GAAP to non-GAAP financial measures. At this stage of our lifecycle, we believe non-GAAP financial results better represent the underlying economics of our business.
Our presenters on today's call are John Jacobs, President and CEO; Dr. Jeffrey Dayno, Chief Medical Officer; Jeffrey Dierks, Chief Commercial Officer; and Sandip Kapadia, CFO.
Moving onto slide two. As a reminder, we will be making forward-looking statements today, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties and our actual results may differ materially. I encourage you to consult the risk
- Read more current HRMY analysis and news
- View all earnings call transcripts